Specificity and detection of insulin-reactive CD4 +T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 40, 2011, Pages 16729-16734

  Crawford, Frances ^a,b   Stadinski, Brian ^a,b,d   Jin, Niyun ^a,b   Michels, Aaron ^c   Nakayama, Maki ^b,c   Pratt, Philip ^c   Marrack, Philippa ^a,b   Eisenbarth, George ^b,c   Kappler, John W ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antigen processing; Autoimmunity; Self tolerance; T cell receptor

Indexed keywords

BINDING PROTEIN; GLUTAMIC ACID; IA G 7 ANTIGEN; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN B 9 23; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA CHAIN; BIOTINYLATION; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL TRACKING; HYBRIDOMA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYBRIDOMAS; INSULIN; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; THYMUS GLAND;

MUS;

EID: 80053628904     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113954108     Document Type: Article

References (39)

1. Lieberman SM, DiLorenzo TP (2003) A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62:359-377. (Pubitemid 37338877)
2. Zhang L, Nakayama M, Eisenbarth GS (2008) Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 20:111-118.
3. Daniel D, Gill RG, Schloot N, Wegmann D (1995) Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062.
4. Abiru N, et al. (2000) Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse. J Autoimmun 14:231-237.
5. Burton AR, et al. (2008) On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57:1321-1330.
6. Levisetti MG, Suri A, Petzold SJ, Unanue ER (2007) The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J Immunol 178:6051-6057. (Pubitemid 46717384)
7. Stadinski BD, et al. (2010) Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci USA 107:10978-10983.
8. Latek RR, et al. (2000) Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12:699-710.
9. Corper AL, et al. (2000) A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288:505-511. (Pubitemid 30236031)
10. Suri A, et al. (2002) In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J Immunol 168:1235-1243. (Pubitemid 34094490)
11. Simone E, et al. (1997) T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci USA 94:2518-2521. (Pubitemid 27136907)
12. Carrasco-Marin E, Shimizu J, Kanagawa O, Unanue ER (1996) The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 156:450-458.
13. Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K (1988) T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444-1448. (Pubitemid 19035999)
14. Stadinski BD, et al. (2010) Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 11:225-231.
15. Kozono H, White J, Clements J, Marrack P, Kappler J (1994) Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151-154. (Pubitemid 24153438)
16. Crawford F, Huseby E, White J, Marrack P, Kappler JW (2004) Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol 2:523-533.
17. Kubo RT, Born W, Kappler JW, Marrack P, Pigeon M (1989) Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. J Immunol 142:2736-2742. (Pubitemid 19114889)
18. Crawford F, Kozono H, White J, Marrack P, Kappler J (1998) Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675-682. (Pubitemid 28294514)
19. Jang MH, Seth NP, Wucherpfennig KW (2003) Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors. J Immunol 171:4175-4186. (Pubitemid 37238694)
20. You S, et al. (2003) Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. J Immunol 170:4011-4020. (Pubitemid 36428162)
21. Mohan JF, et al. (2010) Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 11:350-354.
22. Huseby ES, et al. (2005) How the T cell repertoire becomes peptide and MHC specific. Cell 122:247-260. (Pubitemid 41032988)
23. Dai S, et al. (2010) Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc Natl Acad Sci USA 107:7425-7430.
24. Kersh GJ, et al. (2001) Structural and functional consequences of altering a peptide MHC anchor residue. J Immunol 166:3345-3354. (Pubitemid 33117335)
25. Lovitch SB, Esparza TJ, Schweitzer G, Herzog J, Unanue ER (2007) Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol 178:122-133. (Pubitemid 46033593)
26. Arden SD, et al. (1994) The post-translational processing of chromogranin A in the pancreatic islet: Involvement of the eukaryote subtilisin PC2. Biochem J 298:521-528. (Pubitemid 24085172)
27. He XL, et al. (2002) Structural snapshot of aberrant antigen presentation linked to autoimmunity: The immunodominant epitope of MBP complexed with I-Au. Immunity 17:83-94.
28. Carson RT, Vignali KM, Woodland DL, Vignali DA (1997) T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7:387-399. (Pubitemid 27446013)
29. Vignali DA, Urban RG, Chicz RM, Strominger JL (1993) Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur J Immunol 23:1602-1607. (Pubitemid 23218071)
30. Li Y, et al. (2005) Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J 24:2968-2979. (Pubitemid 41486334)
31. Sethi DK, et al. (2011) A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J Exp Med 208:91-102.
32. Hovhannisyan Z, et al. (2008) The role of HLA-DQ8 beta57 polymorphism in the antigluten T-cell response in coeliac disease. Nature 456:534-538. (Pubitemid 352759011)
33. Feitsma AL, et al. (2010) Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Arthritis Rheum 62:117-125.
34. Hill JA, et al. (2008) Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 205:967-979. (Pubitemid 351549891)
35. Crawford F, et al. (2006) Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands. Immunol Rev 210:156-170.
36. O'Shea EK, Lumb KJ, Kim PS (1993) Peptide 'Velcro': Design of a heterodimeric coiled coil. Curr Biol 3:658-667.
37. Schatz PJ (1993) Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (N Y) 11:1138-1143.
38. Nicolls MR, Coulombe M, Yang H, Bolwerk A, Gill RG (2000) Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J Immunol 164:3627-3634. (Pubitemid 30169816)
39. Kobayashi M, et al. (2008) Conserved T cell receptor alpha-chain induces insulin autoantibodies. Proc Natl Acad Sci USA 105:10090-10094.